{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:38:56Z","timestamp":1793777936388,"version":"4.6.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L011808\/1"],"award-info":[{"award-number":["MR\/L011808\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013126","name":"Psoriasis Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000545","name":"British Association of Dermatologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011111","name":"UCB | UCB UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000296","name":"British Skin Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["RP123188F6A67836"],"award-info":[{"award-number":["RP123188F6A67836"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008271","name":"LEO Pharma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004628","name":"MedImmune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009010","name":"Novartis | Novartis Pharmaceuticals UK Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009360","name":"King's College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009148","name":"Queen Mary University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009148","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite increased understanding of psoriasis pathogenesis, molecular classification of clinical phenotypes and disease severity is poorly defined. Knowledge gaps include whether molecular endotypes of psoriasis underlie distinct clinical phenotypes and the positive and negative molecular regulators of disease severity across tissue compartments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed comprehensive RNA sequencing of skin and blood (n\u2009=\u2009718) from prospectively-recruited, deeply-phenotyped discovery and replication cohorts of 146 subjects with moderate-to-severe chronic plaque psoriasis initiating TNF-inhibitor (adalimumab) or IL-12\/23-inhibitor (ustekinumab) therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here we show, using two complementary dimensionality reduction methods, that co-expressed gene modules and factors within skin and blood are significantly associated with psoriasis phenotypes and disease severity. We identify a 14-gene signature negatively associated with BMI in nonlesional skin and with disease severity in lesional skin. Genotype integration reveals that HLA-DQA1*01 and HLA-DRB1*15 genotypes are positively associated with baseline psoriasis severity. Using explainable machine learning models, we define two disease severity-associated gene modules in lesional skin - one positive, one negatively-associated - and a 9-gene signature in lesional skin predictive of disease severity. Disease severity signatures in blood are only seen following adalimumab exposure, suggesting greater systemic impact of adalimumab compared to ustekinumab, in line with its side effect profile. In contrast, a gene signature in blood linked to HLA-C*06:02 status is independent of disease severity or drug.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings delineate gene-environmental and genetic effects on the psoriasis transcriptome linked to disease severity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-025-01325-4","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:47:26Z","timestamp":1769003246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transcriptomic profiling and machine learning uncover gene signatures of psoriasis endotypes and disease severity"],"prefix":"10.1038","volume":"6","author":[{"given":"Ashley","family":"Rider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3197-4823","authenticated-orcid":false,"given":"Henry J.","family":"Grantham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6967-7691","authenticated-orcid":false,"given":"Graham R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9632-2159","authenticated-orcid":false,"given":"David S.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Casement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6831-9806","authenticated-orcid":false,"given":"Simon J.","family":"Cockell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Gisby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5511-5230","authenticated-orcid":false,"given":"Rafael","family":"Henkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim A.","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9178-9614","authenticated-orcid":false,"given":"Tom","family":"Ewen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8081-8432","authenticated-orcid":false,"given":"Shoba","family":"Amarnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4524-6058","authenticated-orcid":false,"given":"Sandra","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6033-5919","authenticated-orcid":false,"given":"Paolo","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1805-6278","authenticated-orcid":false,"given":"Nick","family":"Dand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Stocken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Traini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanker","family":"Kalyana-Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak K.","family":"Rajpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7833-3102","authenticated-orcid":false,"given":"Kathleen M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan N.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E. M.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2066-7780","authenticated-orcid":false,"given":"Paola","family":"Di Meglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9918-1144","authenticated-orcid":false,"given":"Catherine H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9097-7381","authenticated-orcid":false,"given":"Michael R.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6484-825X","authenticated-orcid":false,"given":"Nick J.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the PSORT consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Di Meglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"1325_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E. & Barker, J. N. W. N. Psoriasis. Lancet Lond. Engl. 397, 1301\u20131315 (2021).","journal-title":"Lancet Lond. Engl."},{"key":"1325_CR2","doi-asserted-by":"publisher","unstructured":"Dand, N. et al. GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets. MedRxivhttps:\/\/doi.org\/10.1101\/2023.10.04.23296543 (2023).","DOI":"10.1101\/2023.10.04.23296543"},{"key":"1325_CR3","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1038\/jid.2015.286","volume":"135","author":"CEM Griffiths","year":"2015","unstructured":"Griffiths, C. E. M. et al. Establishing an Academic-Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant Therapy. J. Invest. Dermatol. 135, 2903\u20132907 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"1325_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03424-4","volume":"9","author":"W Saelens","year":"2018","unstructured":"Saelens, W., Cannoodt, R. & Saeys, Y. A comprehensive evaluation of module detection methods for gene expression data. Nat. Commun. 9, 1090 (2018).","journal-title":"Nat. Commun."},{"key":"1325_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jid.2018.04.041","volume":"139","author":"AC Foulkes","year":"2019","unstructured":"Foulkes, A. C. et al. A framework for multi-omic prediction of treatment response to biologic therapy for psoriasis. J. Invest Dermatol. 139, 100\u2013107 (2019).","journal-title":"J. Invest Dermatol."},{"key":"1325_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-100","volume":"13","author":"Y Guo","year":"2013","unstructured":"Guo, Y., Logan, H. L., Glueck, D. H. & Muller, K. E. Selecting a sample size for studies with repeated measures. BMC Med. Res. Methodol. 13, 100 (2013).","journal-title":"BMC Med. Res. Methodol."},{"key":"1325_CR7","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.jaci.2018.11.038","volume":"143","author":"N Dand","year":"2019","unstructured":"Dand, N. et al. HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis. J. Allergy Clin. Immunol. 143, 2120\u20132130 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1325_CR8","doi-asserted-by":"publisher","first-page":"e64683","DOI":"10.1371\/journal.pone.0064683","volume":"8","author":"X Jia","year":"2013","unstructured":"Jia, X. et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE 8, e64683 (2013).","journal-title":"PLoS ONE"},{"key":"1325_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525\u2013527 (2016).","journal-title":"Nat. Biotechnol."},{"key":"1325_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).","journal-title":"Genome Biol."},{"key":"1325_CR11","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1325_CR12","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440\u20139445 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1325_CR13","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3389\/fgene.2020.00654","volume":"11","author":"F Maleki","year":"2020","unstructured":"Maleki, F., Ovens, K., Hogan, D. J. & Kusalik, A. J. Gene set analysis: challenges, opportunities, and future research. Front. Genet. 11, 654 (2020).","journal-title":"Front. Genet."},{"key":"1325_CR14","unstructured":"Helwig, N. E. ICA: Independent Component Analysis (2022). Available from https:\/\/cran.r-project.org\/web\/packages\/ica\/index.html."},{"key":"1325_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-017-4112-9","volume":"18","author":"U Kairov","year":"2017","unstructured":"Kairov, U. et al. Determining the optimal number of independent components for reproducible transcriptomic data analysis. BMC Genomics. 18, 712 (2017).","journal-title":"BMC Genomics."},{"key":"1325_CR16","unstructured":"Gisby, J. & Barnes, M. Reduced Experiment: Containers and tools for dimensionally-reduced -omics data (2025). Available from http:\/\/www.bioconductor.org\/packages\/ReducedExperiment."},{"key":"1325_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1325_CR18","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.immuni.2020.09.015","volume":"53","author":"TK Hughes","year":"2020","unstructured":"Hughes, T. K. et al. Second-strand synthesis-based massively parallel scRNA-Seq reveals cellular states and molecular features of human inflammatory skin pathologies. Immunity 53, 878\u2013894.e7 (2020).","journal-title":"Immunity"},{"key":"1325_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer, A., Green, J., Pollard, J. & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523\u2013530 (2014).","journal-title":"Bioinformatics"},{"key":"1325_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"1325_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nmeth.4642","volume":"15","author":"D Bzdok","year":"2018","unstructured":"Bzdok, D., Altman, N. & Krzywinski, M. Statistics versus machine learning. Nat. Methods 15, 233\u2013234 (2018).","journal-title":"Nat. Methods"},{"key":"1325_CR22","doi-asserted-by":"crossref","unstructured":"Rasmussen C. E., Williams C. K. I. Gaussian Processes for Machine Learning (MIT Press, 2006). 248 (Adaptive computation and machine learning).","DOI":"10.7551\/mitpress\/3206.001.0001"},{"key":"1325_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/jxb\/erac368","volume":"74","author":"WA Iqbal","year":"2023","unstructured":"Iqbal, W. A., Lisitsa, A. & Kapralov, M. V. Predicting plant Rubisco kinetics from RbcL sequence data using machine learning. J. Exp. Bot. 74, 638\u2013650 (2023).","journal-title":"J. Exp. Bot."},{"key":"1325_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-020-1069-4","volume":"20","author":"LF Cheng","year":"2020","unstructured":"Cheng, L. F. et al. Sparse multi-output Gaussian processes for online medical time series prediction. BMC Med. Inf. Decis. Mak. 20, 152 (2020).","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"1325_CR25","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1093\/bioinformatics\/bty178","volume":"34","author":"KK Yang","year":"2018","unstructured":"Yang, K. K., Wu, Z., Bedbrook, C. N. & Arnold, F. H. Learned protein embeddings for machine learning. Bioinforma. Oxf. Engl. 34, 2642\u20132648 (2018).","journal-title":"Bioinforma. Oxf. Engl."},{"key":"1325_CR26","doi-asserted-by":"publisher","first-page":"10073","DOI":"10.1021\/acs.chemrev.1c00022","volume":"121","author":"VL Deringer","year":"2021","unstructured":"Deringer, V. L. et al. Gaussian process regression for materials and molecules. Chem. Rev. 121, 10073\u201310141 (2021).","journal-title":"Chem. Rev."},{"key":"1325_CR27","unstructured":"Duvenaud, D. K., Nickisch, H. & Rasmussen, C. in Advances in Neural Information Processing Systems (eds Shawe-Taylor J. et al.) (Curran Associates, Inc., 2011). Available from https:\/\/proceedings.neurips.cc\/paper_files\/paper\/2011\/file\/4c5bde74a8f110656874902f07378009-Paper.pdf."},{"key":"1325_CR28","first-page":"1","volume":"18","author":"AG Matthews","year":"2017","unstructured":"Matthews, A. G. et al. GPflow: A Gaussian Process Library using TensorFlow. J. Mach. Learn Res. 18, 1\u20136 (2017).","journal-title":"J. Mach. Learn Res."},{"key":"1325_CR29","unstructured":"Lundberg, S. M. & Lee, S.-I. A Unified Approach to Interpreting Model Predictions. In Curran Associates, Inc.; 2017. 4765-4774."},{"key":"1325_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25066-9","volume":"12","author":"R Andres-Ejarque","year":"2021","unstructured":"Andres-Ejarque, R. et al. Enhanced NF-\u03baB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis. Nat. Commun. 12, 4741 (2021).","journal-title":"Nat. Commun."},{"key":"1325_CR31","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/bjd.20140","volume":"185","author":"N Geifman","year":"2021","unstructured":"Geifman, N. et al. Defining trajectories of response in patients with psoriasis treated with biologic therapies. Br. J. Dermatol. 185, 825\u2013835 (2021).","journal-title":"Br. J. Dermatol."},{"key":"1325_CR32","doi-asserted-by":"crossref","unstructured":"Solvin, \u00c5\u00d8 et al. Meta-analysis of RNA sequencing data from 534 skin samples shows substantial IL-17 effects in non-lesional psoriatic skin (2023). Available from http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.11.03.23298021.","DOI":"10.1101\/2023.11.03.23298021"},{"key":"1325_CR33","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jid.2016.04.032","volume":"136","author":"J Kim","year":"2016","unstructured":"Kim, J. et al. The spectrum of mild to severe psoriasis vulgaris is defined by a common activation of il-17 pathway genes, but with key differences in immune regulatory genes. J. Invest Dermatol. 136, 2173\u20132182 (2016).","journal-title":"J. Invest Dermatol."},{"key":"1325_CR34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"T Fredriksson","year":"1978","unstructured":"Fredriksson, T. & Pettersson, U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 157, 238\u2013244 (1978).","journal-title":"Dermatologica"},{"key":"1325_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39020-4","volume":"14","author":"F Ma","year":"2023","unstructured":"Ma, F. et al. Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis. Nat. Commun. 14, 3455 (2023).","journal-title":"Nat. Commun."},{"key":"1325_CR36","doi-asserted-by":"publisher","first-page":"eabq7991","DOI":"10.1126\/sciimmunol.abq7991","volume":"8","author":"RL Castillo","year":"2023","unstructured":"Castillo, R. L. et al. Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems. Sci. Immunol. 8, eabq7991 (2023).","journal-title":"Sci. Immunol."},{"key":"1325_CR37","doi-asserted-by":"publisher","first-page":"eaba6500","DOI":"10.1126\/science.aba6500","volume":"371","author":"G Reynolds","year":"2021","unstructured":"Reynolds, G. et al. Developmental cell programs are co-opted in inflammatory skin disease. Science 371, eaba6500 (2021).","journal-title":"Science"},{"key":"1325_CR38","doi-asserted-by":"publisher","unstructured":"Steele, L. et al. A single cell and spatial genomics atlas of human skin fibroblasts in health and disease. Cell Biol.https:\/\/doi.org\/10.1101\/2024.12.23.629194 (2024).","DOI":"10.1101\/2024.12.23.629194"},{"key":"1325_CR39","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1038\/jid.2009.173","volume":"129","author":"JE Gudjonsson","year":"2009","unstructured":"Gudjonsson, J. E. et al. Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. J. Invest. Dermatol. 129, 2795\u20132804 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"1325_CR40","doi-asserted-by":"crossref","unstructured":"Rawat, A. et al. A neutrophil-driven inflammatory signature characterizes the blood transcriptome fingerprint of psoriasis. Front. Immunol. 11, 587946 (2024).","DOI":"10.3389\/fimmu.2020.587946"},{"key":"1325_CR41","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3389\/fimmu.2018.00954","volume":"9","author":"JC Prinz","year":"2018","unstructured":"Prinz, J. C. Human leukocyte antigen-class I alleles and the autoreactive T cell response in psoriasis pathogenesis. Front. Immunol. 9, 954 (2018).","journal-title":"Front. Immunol."},{"key":"1325_CR42","doi-asserted-by":"publisher","first-page":"btae172","DOI":"10.1093\/bioinformatics\/btae172","volume":"40","author":"R Henkin","year":"2024","unstructured":"Henkin, R., Goldmann, K., Lewis, M. & Barnes, M. R. shinyExprPortal: a configurable \u2018shiny\u2019 portal for sharing analysis of molecular expression data. Bioinformatics 40, btae172 (2024).","journal-title":"Bioinformatics"},{"key":"1325_CR43","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1001\/jamadermatol.2022.2909","volume":"158","author":"ZZN Yiu","year":"2022","unstructured":"Yiu, Z. Z. N. et al. Drug survival associated with effectiveness and safety of treatment with Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in patients with psoriasis. JAMA Dermatol. 158, 1131 (2022).","journal-title":"JAMA Dermatol."},{"key":"1325_CR44","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/acr.24630","volume":"74","author":"Y Jin","year":"2022","unstructured":"Jin, Y. et al. Risk of hospitalization for serious infection after initiation of Ustekinumab or other biologics in patients with psoriasis or psoriatic arthritis. Arthritis Care Res. 74, 1792\u20131805 (2022).","journal-title":"Arthritis Care Res."},{"key":"1325_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70244-2","volume":"10","author":"JM Walker","year":"2020","unstructured":"Walker, J. M. et al. Obesity and ethnicity alter gene expression in skin. Sci. Rep. 10, 14079 (2020).","journal-title":"Sci. Rep."},{"key":"1325_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","volume":"36","author":"P Gisondi","year":"2018","unstructured":"Gisondi, P., Fostini, A. C., Foss\u00e0, I., Girolomoni, G. & Targher, G. Psoriasis and the metabolic syndrome. Clin. Dermatol. 36, 21\u201328 (2018).","journal-title":"Clin. Dermatol."},{"key":"1325_CR47","doi-asserted-by":"publisher","first-page":"7499","DOI":"10.3390\/ijms23147499","volume":"23","author":"G Barros","year":"2022","unstructured":"Barros, G., Duran, P., Vera, I. & Berm\u00fadez, V. Exploring the links between obesity and psoriasis: a comprehensive review. Int J. Mol. Sci. 23, 7499 (2022).","journal-title":"Int J. Mol. Sci."},{"key":"1325_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2184.2009.00650.x","volume":"43","author":"JR Park","year":"2010","unstructured":"Park, J. R. et al. DNER modulates adipogenesis of human adipose tissue-derived mesenchymal stem cells via regulation of cell proliferation. Cell Prolif. 43, 19\u201328 (2010).","journal-title":"Cell Prolif."},{"key":"1325_CR49","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2337\/db13-0416","volume":"63","author":"RL Hanson","year":"2014","unstructured":"Hanson, R. L. et al. A genome-wide association study in american indians implicates DNER as a susceptibility locus for type 2 diabetes. Diabetes 63, 369\u2013376 (2014).","journal-title":"Diabetes"},{"key":"1325_CR50","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/bjd.13128","volume":"171","author":"AJ Onderdijk","year":"2014","unstructured":"Onderdijk, A. J. et al. Regulated genes in psoriatic skin during treatment with fumaric acid esters. Br. J. Dermatol. 171, 732\u2013741 (2014).","journal-title":"Br. J. Dermatol."},{"key":"1325_CR51","doi-asserted-by":"publisher","first-page":"244ra90","DOI":"10.1126\/scitranslmed.3008946","volume":"6","author":"M Quaranta","year":"2014","unstructured":"Quaranta, M. et al. Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. Sci. Transl. Med. 6, 244ra90 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1325_CR52","doi-asserted-by":"publisher","first-page":"6337","DOI":"10.3390\/ijms24076337","volume":"24","author":"K Errafii","year":"2023","unstructured":"Errafii, K., Boujraf, S. & Chikri, M. Transcriptomic analysis from normal glucose tolerance to T2D of obese individuals using bioinformatic tools. Int J. Mol. Sci. 24, 6337 (2023).","journal-title":"Int J. Mol. Sci."},{"key":"1325_CR53","doi-asserted-by":"publisher","first-page":"1334844","DOI":"10.3389\/fimmu.2024.1334844","volume":"15","author":"P Seiringer","year":"2024","unstructured":"Seiringer, P. et al. Spatial transcriptomics reveals altered lipid metabolism and inflammation-related gene expression of sebaceous glands in psoriasis and atopic dermatitis. Front. Immunol. 15, 1334844 (2024).","journal-title":"Front. Immunol."},{"key":"1325_CR54","unstructured":"Mishra, S. et al. Inhibition of phosphodiesterase type 9 reduces obesity and cardiometabolic syndrome in mice.(American Society for Clinical Investigation, 2021). Available from https:\/\/www.jci.org\/articles\/view\/148798\/pdf."},{"key":"1325_CR55","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.immuni.2023.06.021","volume":"56","author":"P Sivasami","year":"2023","unstructured":"Sivasami, P. et al. Obesity-induced dysregulation of skin-resident PPAR\u03b3+ Treg cells promotes IL-17A-mediated psoriatic inflammation. Immunity 56, 1844\u20131861.e6 (2023).","journal-title":"Immunity"},{"key":"1325_CR56","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/09546634.2019.1610552","volume":"31","author":"G Chang","year":"2020","unstructured":"Chang, G., Wang, J., Song, J., Zhang, Z. & Zhang, L. Efficacy and safety of pioglitazone for treatment of plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials. J. Dermatol. Treat. 31, 680\u2013686 (2020).","journal-title":"J. Dermatol. Treat."},{"key":"1325_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12918-019-0698-7","volume":"13","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Anti-TNF- \u03b1treatment-related pathways and biomarkers revealed by transcriptome analysis in Chinese psoriasis patients. BMC Syst. Biol. 13, 29 (2019).","journal-title":"BMC Syst. Biol."},{"key":"1325_CR58","doi-asserted-by":"publisher","first-page":"964274","DOI":"10.3389\/fimmu.2022.964274","volume":"13","author":"A Grivas","year":"2022","unstructured":"Grivas, A. et al. Combined - whole blood and skin fibroblasts- transcriptomic analysis in Psoriatic Arthritis reveals molecular signatures of activity, resistance and early response to treatment. Front. Immunol. 13, 964274 (2022).","journal-title":"Front. Immunol."},{"key":"1325_CR59","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/bjd.16083","volume":"178","author":"L Chen","year":"2018","unstructured":"Chen, L. & Tsai, T. F. HLA-Cw6 and psoriasis. Br. J. Dermatol. 178, 854\u2013862 (2018).","journal-title":"Br. J. Dermatol."},{"key":"1325_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-06015-8","volume":"23","author":"M Zhang","year":"2025","unstructured":"Zhang, M. et al. Multi-ancestry genome-wide meta-analysis with 472,819 individuals identifies 32 novel risk loci for psoriasis. J. Transl. Med. 23, 133 (2025).","journal-title":"J. Transl. Med."},{"key":"1325_CR61","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/j.jid.2021.04.020","volume":"141","author":"A Chandra","year":"2021","unstructured":"Chandra, A. et al. Functional mapping of genetic interactions between HLA-Cw6 and LCE3A in psoriasis. J. Invest. Dermatol. 141, 2630\u20132638.e7 (2021).","journal-title":"J. Invest. Dermatol."},{"key":"1325_CR62","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.3389\/fimmu.2018.02830","volume":"9","author":"CC Hsiao","year":"2018","unstructured":"Hsiao, C. C. et al. The adhesion G protein-coupled receptor GPR97\/ADGRG3 is expressed in human granulocytes and triggers antimicrobial effector functions. Front. Immunol. 9, 2830 (2018).","journal-title":"Front. Immunol."},{"key":"1325_CR63","doi-asserted-by":"publisher","first-page":"100069","DOI":"10.1016\/j.xhgg.2021.100069","volume":"3","author":"PE Stuart","year":"2022","unstructured":"Stuart, P. E. et al. Transethnic analysis of psoriasis susceptibility in South Asians and Europeans enhances fine mapping in the MHC and genome wide. Hum. Genet. Genomics Adv. 3, 100069 (2022).","journal-title":"Hum. Genet. Genomics Adv."},{"key":"1325_CR64","doi-asserted-by":"publisher","first-page":"e13641","DOI":"10.1111\/srt.13641","volume":"30","author":"H Lei","year":"2024","unstructured":"Lei, H. et al. Exploration of the causality of frailty index on psoriasis: a Mendelian randomization study. Skin Res. Technol. 30, e13641 (2024).","journal-title":"Skin Res. Technol."},{"key":"1325_CR65","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1365-4632.2004.02098.x","volume":"43","author":"X Zhang","year":"2004","unstructured":"Zhang, X. et al. HLA-DQA1 and DQB1 alleles are associated with genetic susceptibility to psoriasis vulgaris in Chinese Han. Int J. Dermatol. 43, 181\u2013187 (2004).","journal-title":"Int J. Dermatol."},{"key":"1325_CR66","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2337\/db15-1105","volume":"65","author":"A Pugliese","year":"2016","unstructured":"Pugliese, A. et al. HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 haplotype protects autoantibody-positive relatives from type 1 diabetes throughout the stages of disease progression. Diabetes 65, 1109\u20131119 (2016).","journal-title":"Diabetes"},{"key":"1325_CR67","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3389\/fimmu.2018.01390","volume":"9","author":"F Casciano","year":"2018","unstructured":"Casciano, F., Pigatto, P. D., Secchiero, P., Gambari, R. & Reali, E. T. Cell hierarchy in the pathogenesis of psoriasis and associated cardiovascular comorbidities. Front. Immunol. 9, 1390 (2018).","journal-title":"Front. Immunol."},{"key":"1325_CR68","doi-asserted-by":"crossref","unstructured":"Romero, P. A., Krause, A. & Arnold, F. H. Navigating the protein fitness landscape with Gaussian processes. Proc. Natl. Acad. Sci. 110, E193\u2013201 (2013).","DOI":"10.1073\/pnas.1215251110"},{"key":"1325_CR69","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41592-019-0496-6","volume":"16","author":"KK Yang","year":"2019","unstructured":"Yang, K. K., Wu, Z. & Arnold, F. H Machine-learning-guided directed evolution for protein engineering. Nat. Methods 16, 687\u2013694 (2019).","journal-title":"Nat. Methods"},{"key":"1325_CR70","doi-asserted-by":"crossref","unstructured":"Brodmerkel, C. et al. Modulation of inflammatory gene transcripts in psoriasis vulgaris: differences between ustekinumab and etanercept. J. Allergy Clin. Immunol. 143, 1965\u20131969 (2019).","DOI":"10.1016\/j.jaci.2019.01.017"},{"key":"1325_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44994-w","volume":"15","author":"L Francis","year":"2024","unstructured":"Francis, L. et al. Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade. Nat. Commun. 15, 913 (2024).","journal-title":"Nat. Commun."},{"key":"1325_CR72","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1194\/jlr.M027185","volume":"53","author":"Y Xiao","year":"2012","unstructured":"Xiao, Y. & Guengerich, F. P. Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids. J. Lipid Res. 53, 1610\u20131617 (2012).","journal-title":"J. Lipid Res."},{"key":"1325_CR73","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1124\/dmd.116.069633","volume":"44","author":"Y Zhao","year":"2016","unstructured":"Zhao, Y., Wan, D., Yang, J., Hammock, B. D. & Ortiz De Montellano, P. R. Catalytic activities of tumor-specific human cytochrome P450 CYP2W1 toward endogenous substrates. Drug Metab. Dispos. 44, 771\u2013780 (2016).","journal-title":"Drug Metab. Dispos."},{"key":"1325_CR74","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/genes11101155","volume":"11","author":"G Rioux","year":"2020","unstructured":"Rioux, G. et al. Transcriptome profiling analyses in psoriasis: a dynamic contribution of keratinocytes to the pathogenesis. Genes 11, 1155 (2020).","journal-title":"Genes"},{"key":"1325_CR75","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jaci.2020.05.044","volume":"147","author":"C Li","year":"2021","unstructured":"Li, C. et al. Psoriasis-associated impairment of CCL27\/CCR10-derived regulation leads to IL-17A\/IL-22\u2013producing skin T-cell overactivation. J. Allergy Clin. Immunol. 147, 759\u2013763.e9 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1325_CR76","doi-asserted-by":"publisher","first-page":"re3","DOI":"10.1126\/scisignal.272re3","volume":"2","author":"RL Silverstein","year":"2009","unstructured":"Silverstein, R. L. & Febbraio, M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal. 2, re3 (2009).","journal-title":"Sci. Signal."},{"key":"1325_CR77","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.ygeno.2018.09.011","volume":"111","author":"S Das","year":"2019","unstructured":"Das, S., Majumder, P. P., Chatterjee, R., Chatterjee, A. & Mukhopadhyay, I. A powerful method to integrate genotype and gene expression data for dissecting the genetic architecture of a disease. Genomics 111, 1387\u20131394 (2019).","journal-title":"Genomics"},{"key":"1325_CR78","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1365-2133.2006.07743.x","volume":"156","author":"N Komatsu","year":"2007","unstructured":"Komatsu, N. et al. Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy. Br. J. Dermatol. 156, 875\u2013883 (2007).","journal-title":"Br. J. Dermatol."},{"key":"1325_CR79","doi-asserted-by":"publisher","first-page":"7731082","DOI":"10.1155\/2022\/7731082","volume":"2022","author":"L Xing","year":"2022","unstructured":"Xing, L. et al. Exploration of biomarkers of psoriasis through combined multiomics analysis. Mediators Inflamm. 2022, 7731082 (2022).","journal-title":"Mediators Inflamm."},{"key":"1325_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.976","volume":"12","author":"J Deng","year":"2022","unstructured":"Deng, J. et al. Multi-omics integration reveals a core network involved in host defence and hyperkeratinization in psoriasis. Clin. Transl. Med. 12, e976 (2022).","journal-title":"Clin. Transl. Med."},{"key":"1325_CR81","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s40618-020-01492-2","volume":"44","author":"G Mancino","year":"2021","unstructured":"Mancino, G., Miro, C., Di Cicco, E. & Dentice, M. Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin. J. Endocrinol. Invest. 44, 1571\u20131579 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"1325_CR82","doi-asserted-by":"publisher","first-page":"16219","DOI":"10.1073\/pnas.1408886111","volume":"111","author":"R Zhang","year":"2014","unstructured":"Zhang, R., Lahens, N. F., Ballance, H. I., Hughes, M. E. & Hogenesch, J. B. A circadian gene expression atlas in mammals: Implications for biology and medicine. Proc. Natl. Acad. Sci. 111, 16219\u201316224 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1325_CR83","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1073\/pnas.1915773117","volume":"117","author":"EN Greenberg","year":"2020","unstructured":"Greenberg, E. N. et al. Circadian control of interferon-sensitive gene expression in murine skin. Proc. Natl. Acad. Sci. USA 117, 5761\u20135771 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1325_CR84","first-page":"988","volume":"15","author":"M Chow","year":"2016","unstructured":"Chow, M. et al. Effect of adalimumab on gene expression profiles of psoriatic skin and blood. J. Drugs Dermatol. 15, 988\u2013994 (2016).","journal-title":"J. Drugs Dermatol."},{"key":"1325_CR85","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/jid.2012.184","volume":"132","author":"M Su\u00e1rez-Fari\u00f1as","year":"2012","unstructured":"Su\u00e1rez-Fari\u00f1as, M. et al. Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J. Invest. Dermatol. 132, 2552\u20132564 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"1325_CR86","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/bjd.21627","volume":"187","author":"R Ramessur","year":"2022","unstructured":"Ramessur, R. et al. Biomarkers of disease progression in people with psoriasis: a scoping review. Br. J. Dermatol. 187, 481\u2013493 (2022).","journal-title":"Br. J. Dermatol."},{"key":"1325_CR87","unstructured":"Rider, A. et al. C4TB\/PSORT: First release. Zenodo Available from https:\/\/zenodo.org\/doi\/10.5281\/zenodo.15847636 (2025)."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01325-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01325-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01325-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:05:23Z","timestamp":1769612723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01325-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1325"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01325-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.07.29.666780","asserted-by":"object"}]},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.J.R. has received, through Newcastle University, grants from Novartis and UCB outside the submitted work; travel support and\/or consultancy income from AbbVie, Boehringer Ingelheim, Galderma, and UCB. M.R.B. has received research funding from Janssen and Benevolent AI, and consultancy with United Health group, Eli Lilly and Sanofi. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}